Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 3
2005 2
2006 2
2007 1
2008 5
2009 4
2010 2
2011 1
2012 4
2013 1
2014 4
2015 5
2016 6
2017 9
2018 12
2019 10
2020 11
2021 13
2022 14
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Meta-analysis in allergy-Statistical recommendations.
Ordak M, Canonica GW, Paoletti G, Brussino L, Carvalho D, Di Bona D. Ordak M, et al. Among authors: di bona d. Allergy. 2024 Feb 29. doi: 10.1111/all.16091. Online ahead of print. Allergy. 2024. PMID: 38425079 No abstract available.
IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies.
Di Bona D, Carlucci P, Spataro F, Paoletti G, Cognet-Sicé J, Scurati S, Canonica GW. Di Bona D, et al. J Allergy Clin Immunol Glob. 2024 Jan 9;3(2):100208. doi: 10.1016/j.jacig.2024.100208. eCollection 2024 May. J Allergy Clin Immunol Glob. 2024. PMID: 38328804 Free PMC article.
An update on nonsteroidal anti-inflammatory drug-induced urticaria.
Miniello A, Casella R, Loverre T, Aloia D, Di Bona D, Nettis E. Miniello A, et al. Among authors: di bona d. Endocr Metab Immune Disord Drug Targets. 2023 Sep 7. doi: 10.2174/1871530323666230907112453. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37691219
Latex allergy - from discovery to component-resolved diagnosis.
Loverre T, Casella R, Miniello A, Di Bona D, Nettis E. Loverre T, et al. Among authors: di bona d. Endocr Metab Immune Disord Drug Targets. 2023 Sep 1. doi: 10.2174/1871530323666230901102131. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37680164
GM Allotypes and COVID-19. A Pilot Study Performed on Sicilian Patients.
Ligotti ME, Calabrò A, Accardi G, Aiello A, Caruso C, Colomba C, Di Bona D, Duro G, Namboodiri AM, Tuttolomondo A, Pandey JP, Candore G. Ligotti ME, et al. Among authors: di bona d. Transl Med UniSa. 2022 Dec 27;24(2):26-29. doi: 10.37825/2239-9747.1039. eCollection 2022. Transl Med UniSa. 2022. PMID: 37476201 Free PMC article.
Editorial: pharmacotherapy and evidence-based medicine section.
Paoletti G, Costanzo G, Del Moro L, Spataro F, Carlucci P, Di Bona D. Paoletti G, et al. Among authors: di bona d. Curr Opin Allergy Clin Immunol. 2023 Aug 1;23(4):307-308. doi: 10.1097/ACI.0000000000000919. Curr Opin Allergy Clin Immunol. 2023. PMID: 37431549 No abstract available.
106 results